Valuation: Acura Pharmaceuticals, Inc.

Market Cap 3.28M 2.84M 2.66M 2.43M 4.57M 313M 4.64M 31.37M 12.25M 157M 12.31M 12.04M 523M P/E 2020
-5.25x
P/E 2021 -25x
Enterprise Value 3.41M 2.96M 2.77M 2.53M 4.76M 326M 4.83M 32.66M 12.75M 163M 12.82M 12.54M 544M EV / Sales 2020
2.91x
EV / Sales 2021 20.9x
Free-Float
98.31%
Yield 2020 *
-
Yield 2021 -
1 day-80.00%
1 week-50.00%
3 months-50.00%
6 months-80.00%
Current year-80.00%
1 week 0
Extreme 0.0001
0
1 month 0
Extreme 0.0001
0
Current year 0
Extreme 1.0E-6
0.01
1 year 0
Extreme 1.0E-6
0.01
3 years 0
Extreme 1.0E-6
0.75
5 years 0
Extreme 1.0E-6
0.75
10 years 0
Extreme 0
1.87
Manager TitleAgeSince
Chief Executive Officer 67 2011-03-31
Director of Finance/CFO 62 2024-07-31
Chief Tech/Sci/R&D Officer 69 2009-01-31
Director TitleAgeSince
Chairman 75 1996-09-30
Director/Board Member 55 2002-11-30
Director/Board Member 83 1998-02-28
Date Insider Type Main position Quantity % Market Cap.
1/2/26 Fiscal year

Director

150,000 0.2273%
1/2/26 Fiscal year

Director

150,000 0.2273%
1/2/26 Fiscal year

Director

150,000 0.2273%
Change 5-day change 1-year change 3-year change Capi.($)
-80.00%-50.00%-80.00%-75.00% 6.66K
+2.07%+13.76%+65.44%+106.53% 70.1B
-0.87%+0.08%+36.96%+65.91% 54.93B
-4.50%-4.69%+2.82%+463.22% 28.89B
+0.39%-0.31%+48.35%+7.45% 23.9B
-0.67%+1.02%-18.32%-13.84% 23.3B
+0.35%+12.02%+257.19%+466.50% 18.41B
-0.59%+7.88%+40.87%-20.56% 18.77B
-0.48%-3.24%+20.39%+615.07% 16.1B
+0.46%-3.05%+31.49%+135.18% 12.48B
Average -8.44%+4.24%+40.52%+175.04% 26.69B
Weighted average by Cap. -0.22%+3.98%+51.15%+165.30%

Financials

2020 2021
Net sales 3.57M 3.09M 2.9M 2.65M 4.98M 341M 5.06M 34.16M 13.33M 171M 13.4M 13.11M 569M 1.56M 1.35M 1.27M 1.16M 2.18M 149M 2.21M 14.95M 5.84M 74.67M 5.87M 5.74M 249M
Net income -1.21M -1.05M -982K -895K -1.68M -115M -1.71M -11.56M -4.51M -57.71M -4.54M -4.44M -193M -879K -762K -714K -651K -1.23M -83.89M -1.25M -8.41M -3.28M -41.99M -3.3M -3.23M -140M
Net Debt 5.86M 5.08M 4.76M 4.34M 8.16M 559M 8.29M 56.03M 21.87M 280M 21.99M 21.51M 933M 135K 117K 110K 100K 188K 12.88M 191K 1.29M 504K 6.45M 507K 496K 21.52M
Logo Acura Pharmaceuticals, Inc.
Acura Pharmaceuticals, Inc. is a drug delivery company engaged in the research, development, and commercialization of technologies and products to address the safe use of medications. Its platform technologies include LIMITX Technology, AVERSION Technology, and IMPEDE Technology. Its LIMITX Technology is designed to minimize the risks and side effects associated with overdose by retarding the release of active drug ingredients when too many tablets are accidentally or purposefully ingested. The LIMITX Technology is in development with hydrocodone bitartrate and acetaminophen (also known as LTX-03) as the lead product candidates. Its AVERSION Technology is to address methods of product tampering associated with opioid abuse by incorporating gelling ingredients and irritants into tablets to discourage abuse by snorting and provide barriers to abuse by injection. Its IMPEDE Technology is directed at minimizing the extraction and conversion of pseudoephedrine tablets into methamphetamine.
Employees
-
Date Price Change Volume
26-08-13 US$0.000100 -.--% 6,600
26-08-11 US$0.000100 -50.00% 200
26-08-06 US$0.000200 +100.00% 959
  1. Stock Market
  2. Stocks
  3. ACUR Stock